U.S. Markets closed

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.25+0.11 (+1.79%)
At close: 4:00PM EDT

6.27 +0.02 (0.32%)
After hours: 4:58PM EDT

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.48
52-Week Change 3-30.70%
S&P500 52-Week Change 3N/A
52 Week High 317.37
52 Week Low 32.93
50-Day Moving Average 36.63
200-Day Moving Average 37.42

Share Statistics

Avg Vol (3 month) 36.25M
Avg Vol (10 day) 33.5M
Shares Outstanding 587.99M
Float 69.72M
% Held by Insiders 12.27%
% Held by Institutions 148.46%
Shares Short (Jul 14, 2020) 432.65M
Short Ratio (Jul 14, 2020) 47.74
Short % of Float (Jul 14, 2020) 438.20%
Short % of Shares Outstanding (Jul 14, 2020) 437.11%
Shares Short (prior month Jun 14, 2020) 426.06M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020


Profit Margin -271.13%
Operating Margin (ttm)-238.84%

Management Effectiveness

Return on Assets (ttm)-32.83%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)152.45M
Revenue Per Share (ttm)2.60
Quarterly Revenue Growth (yoy)28.50%
Gross Profit (ttm)113.08M
EBITDA -355.94M
Net Income Avi to Common (ttm)-413.34M
Diluted EPS (ttm)-7.06
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)228.36M
Total Cash Per Share (mrq)2.97
Total Debt (mrq)610.45M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.47
Book Value Per Share (mrq)-1.73

Cash Flow Statement

Operating Cash Flow (ttm)-307.66M
Levered Free Cash Flow (ttm)-152.2M